Akèy › Anplwayè › InvaGen Pharmaceuticals, Inc. › QC Chemist II
QC Chemist II nan InvaGen Pharmaceuticals, Inc.: Salè H-1B
5 aplikasyon kondisyon travay pou tit travay QC Chemist II nan InvaGen Pharmaceuticals, Inc.. Salè baz medyàn ofri $80,000; mwatye mitan $80,000–$81,000.
Demann (LCA)5
Salè medyan ofri$80,000
Mwatye salè yo$80,000–$81,000
10yèm–90yèm pousantaj$74,000–$81,600
Pa ane fiskal
| Ane fiskal | LCA | Salè medyan |
|---|---|---|
| FY2024 | 3 | $80,000 |
| FY2025 | 2 | $81,500 |
Aplikasyon
| Salè baz | Kote | Soumèt | Dat kòmansman | Estati |
|---|---|---|---|---|
| $81,000 Nivo II | Hauppauge, NY | Aug 28, 2025 | Sep 29, 2025 | Certifye |
| $82,000 Nivo II | Central lslip, NY | Nov 11, 2024 | Dec 16, 2024 | Certifye |
| $70,000 Nivo I | Fall River, MA | Jun 17, 2024 | Jun 24, 2024 | Certifye |
| $80,000 Nivo II | Fall River, MA | Apr 30, 2024 | May 6, 2024 | Certifye |
| $80,000 Nivo II | Central lslip, NY | Mar 14, 2024 | Mar 14, 2024 | Certifye |
Lòt travay nan InvaGen Pharmaceuticals, Inc.
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).